期刊文献+

Calcium channel blockers and Alzheimer's disease 被引量:2

Calcium channel blockers and Alzheimer’s disease
下载PDF
导出
摘要 Alzheimer's disease is characterized by two pathological hallmarks: amyloid plaques and neurofibrillary tangles. In addition, calcium homeostasis is disrupted in the course of human aging Recent research shows that dense plaques can cause functional alteration of calcium signals in mice with Alzheimer's disease. Calcium channel blockers are effective therapeutics for treating Alzheimer's disease. This review provides an overview of the current research of calcium channel blockers involved in Alzheimer's disease theraov. Alzheimer's disease is characterized by two pathological hallmarks: amyloid plaques and neurofibrillary tangles. In addition, calcium homeostasis is disrupted in the course of human aging Recent research shows that dense plaques can cause functional alteration of calcium signals in mice with Alzheimer's disease. Calcium channel blockers are effective therapeutics for treating Alzheimer's disease. This review provides an overview of the current research of calcium channel blockers involved in Alzheimer's disease theraov.
机构地区 School of Life Science
出处 《Neural Regeneration Research》 SCIE CAS CSCD 2012年第2期137-140,共4页 中国神经再生研究(英文版)
基金 supported by the National Natural Science Foundation of China, No. 81171206
关键词 Alzheimer's disease caic-ium channel calcium homeostasis Alzheimer's diseasepathogenesis Β-AMYLOID calcium channel blocker Alzheimer's disease caic-ium channel calcium homeostasis Alzheimer's diseasepathogenesis β-amyloid calcium channel blocker
  • 相关文献

参考文献40

  • 1Emilsson L, Saetre P, Jazin E. Alzheimer's disease: mRNA expression profiles of multiple patients show alterations of genes involved with calcium signaling. Neurobiol Dis. 2006;21(3): 618-625.
  • 2Diaz JC, Simakova O, Jacobson KA, et al. Small molecule blockers of the Alzheimer Abeta calcium channel potently protect neurons from Abeta cytotoxicity. Proc Natl Acad Sci U S A. 2009; 106(9):3348-3353.
  • 3Demuro A, Parker I, Stutzmann GE. Calcium signaling and amyloid toxicity in Alzheimer disease. J Biol Chem. 2010;285(17): 12463-12468.
  • 4Kawahara M, Kuroda Y. Molecular mechanism of neurodegeneration induced by Alzheimer's beta-amyloid protein: channel formation and disruption of calcium homeostasis. Brain Res Bull. 2000;53(4):389-397.
  • 5Bezprozvanny I, Mattson MP. Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease. Trends Neurosci. 2008; 31(9):454-463.
  • 6Chan CS, Guzman JN, Ilijic E, et al. ‘Rejuvenation’protects neurons inmouse models of Parkinson’s disease. Nature. 2007; 447:1081-1086.
  • 7Hardy J. The amyloid hypothesis for Alzheimer’s disease: a critical reappraisal. J Neurochem. 2009;110:1129-1134.
  • 8Anekonda TS, Quinn JF, Harris C, et al. L-type voltage-gated calcium channel blockade with isradipine as a therapeutic strategy for Alzheimer's disease. Neurobiol Dis. 2011;41:62-70.
  • 9Zhang GR, Cheng XR, Zhou WX, et al. Age-related expression of calcium/calmodulin-dependent protein kinase II A in the hippocampus and cerebral cortex of senescence accelerated mouse prone/8 mice is modulated by anti-Alzheimer's disease drugs. Neuroscience. 2009;159(1):308-315.
  • 10Kelliher M, Fastbom J, Cowburn RF, et al. Alterations in the ryanodine receptor calcium release channel correlate with Alzheimer's disease neurofibrillary and beta-amyloid pathologies. Neuroscience. 1999;92(2):499-513.

同被引文献28

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部